Effects of endoscopic mucosal resection in patients with low-grade intraepithelial dysplasia of esophageal squamous cells.
BACKGROUND
This study evaluated the effects of endoscopic mucosal resection (EMR) on patients with low-grade intraepithelial dysplasia (LGD) of the esophageal squamous cells.


METHODS
A randomized study recruited 128 LGD patients. These patients were randomly divided into treatment and control groups after the preoperative examination. The treatment group was composed of 63 LGD cases who received EMR. The control group included 65 LGD cases that were not treated with EMR. Clinical interviews and endoscopy were conducted after 30 months as postoperative follow-up.


RESULTS
Concerning the percentages of esophageal lesions that changed from serious conditions into slight conditions (namely from high-grade intraepithelial dysplasia (HGD) to LGD, basal cell hyperplasia, esophagitis and normal mucosa) there was a significantly linear trend relationship between the treatment group and control group. In downstaging of dysplasia grade, the total percentage for the 52 cases (82.5%) in the treatment group was significantly higher than that for the 32 cases (49.2%) in the control group (Pearson χ(2) = 15.734, p < 0.001). Also, in patients that remained at the LGD grade or had upstaging of their dysplasia grade, the proportions of the change were significantly different between the two groups.


CONCLUSIONS
The percentage rate of regression of LGD was increased in the EMR treatment group as compared to that of the control group. EMR may prevent or delay the progression of LGD to HGD.
Tumor Center, Qilu Hospital of Shandong University, Jinan, PR China.
Hao
H
Li
Juan Li
JL
Cheng
Ning Ning
NN
Dong
Chun Yong
CY
Cui
Tao Yu
TY
Diao
Xue Rui
XR
Zhou
D000230:Adenocarcinoma / Q000473:pathology / Q000601:surgery; D001706:Biopsy; D002278:Carcinoma in Situ / Q000473:pathology / Q000601:surgery*; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000601:surgery; D003937:Diagnosis, Differential; D018450:Disease Progression; D016099:Endoscopy, Gastrointestinal; D004935:Esophageal Diseases / Q000473:pathology / Q000601:surgery; D004938:Esophageal Neoplasms / Q000473:pathology* / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000473:pathology; D060787:Neoplasm Grading; D018295:Neoplasms, Basal Cell / Q000473:pathology; D009385:Neoplastic Processes; D011230:Precancerous Conditions / Q000473:pathology* / Q000601:surgery*; D012074:Remission Induction; D016896:Treatment Outcome